Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Automated Online Quantification Method for 18F-FDG Positron Emission Tomography/CT Improves Detection of the Epileptogenic Zone in Patients with Pharmacoresistant Epilepsy.

Mendes Coelho VC, Morita ME, Amorim BJ, Ramos CD, Yasuda CL, Tedeschi H, Ghizoni E, Cendes F.

Front Neurol. 2017 Sep 1;8:453. doi: 10.3389/fneur.2017.00453. eCollection 2017.

2.

The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery.

Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS.

Epilepsy Res. 2014 Oct;108(8):1306-14. doi: 10.1016/j.eplepsyres.2014.06.012. Epub 2014 Jul 7.

PMID:
25043753
3.

18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.

Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, Bouilleret V, Myers DE, Cook MJ, Hicks RJ, O'Brien TJ.

J Nucl Med. 2013 Aug;54(8):1270-7. doi: 10.2967/jnumed.112.107359. Epub 2013 Jul 15.

4.

Factors affecting bilateral temporal lobe hypometabolism on 18F-FDG PET brain scan in unilateral medial temporal lobe epilepsy.

Tepmongkol S, Srikijvilaikul T, Vasavid P.

Epilepsy Behav. 2013 Nov;29(2):386-9. doi: 10.1016/j.yebeh.2013.08.017. Epub 2013 Sep 26.

PMID:
24074882
5.

The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy.

Gok B, Jallo G, Hayeri R, Wahl R, Aygun N.

Neuroradiology. 2013 May;55(5):541-50. doi: 10.1007/s00234-012-1121-x. Epub 2012 Dec 8.

PMID:
23223825
6.

Epilepsy duration impacts on brain glucose metabolism in temporal lobe epilepsy: results of voxel-based mapping.

Akman CI, Ichise M, Olsavsky A, Tikofsky RS, Van Heertum RL, Gilliam F.

Epilepsy Behav. 2010 Mar;17(3):373-80. doi: 10.1016/j.yebeh.2009.12.007. Epub 2010 Feb 10.

PMID:
20149754
7.

18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI.

Desarnaud S, Mellerio C, Semah F, Laurent A, Landre E, Devaux B, Chiron C, Lebon V, Chassoux F.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1449-1460. doi: 10.1007/s00259-018-3994-3. Epub 2018 Mar 29. Erratum in: Eur J Nucl Med Mol Imaging. 2018 Apr 28;:.

PMID:
29594410
8.

'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study.

Carne RP, O'Brien TJ, Kilpatrick CJ, Macgregor LR, Litewka L, Hicks RJ, Cook MJ.

BMC Neurol. 2007 Jun 24;7:16.

9.

Identification of frontal lobe epileptic foci in children using positron emission tomography.

da Silva EA, Chugani DC, Muzik O, Chugani HT.

Epilepsia. 1997 Nov;38(11):1198-208.

10.

(18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis.

Kim YK, Lee DS, Lee SK, Chung CK, Chung JK, Lee MC.

J Nucl Med. 2002 Sep;43(9):1167-74.

11.

Clinical Role of Subtraction Ictal SPECT Coregistered to MR Imaging and (18)F-FDG PET in Pediatric Epilepsy.

Perissinotti A, Setoain X, Aparicio J, Rubí S, Fuster BM, Donaire A, Carreño M, Bargalló N, Rumiá J, Garcia-Fructuoso G, Mayoral M, Sanmartí F, Pons F.

J Nucl Med. 2014 Jul;55(7):1099-105. doi: 10.2967/jnumed.113.136432. Epub 2014 May 5.

12.

Diffusion tensor imaging can localize the epileptogenic zone in nonlesional extra-temporal refractory epilepsies when [(18)F]FDG-PET is not contributive.

Thivard L, Bouilleret V, Chassoux F, Adam C, Dormont D, Baulac M, Semah F, Dupont S.

Epilepsy Res. 2011 Nov;97(1-2):170-82. doi: 10.1016/j.eplepsyres.2011.08.005. Epub 2011 Aug 31.

PMID:
21885254
13.

Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy.

Rubí S, Setoain X, Donaire A, Bargalló N, Sanmartí F, Carreño M, Rumià J, Calvo A, Aparicio J, Campistol J, Pons F.

Epilepsia. 2011 Dec;52(12):2216-24. doi: 10.1111/j.1528-1167.2011.03295.x. Epub 2011 Nov 2.

14.

Positron emission tomography in presurgical localization of epileptic foci.

Csaba J.

Ideggyogy Sz. 2003 Jul 20;56(7-8):249-54.

PMID:
12971120
15.

Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation.

Bagci U, Kramer-Marek G, Mollura DJ.

EJNMMI Res. 2013 Jul 5;3(1):49. doi: 10.1186/2191-219X-3-49.

16.

(18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy.

Hodolic M, Topakian R, Pichler R.

Radiol Oncol. 2016 Jul 19;50(3):247-53. doi: 10.1515/raon-2016-0032. eCollection 2016 Sep 1. Review.

17.

18FDG-PET in different subtypes of temporal lobe epilepsy: SEEG validation and predictive value.

Guedj E, Bonini F, Gavaret M, Trébuchon A, Aubert S, Boucekine M, Boyer L, Carron R, McGonigal A, Bartolomei F.

Epilepsia. 2015 Mar;56(3):414-21. doi: 10.1111/epi.12917. Epub 2015 Feb 23.

18.

Use of interictal (18)F-fluorodeoxyglucose (FDG)-PET and magnetoencephalography (MEG) to localize epileptogenic foci in non-lesional epilepsy in a cohort of 16 patients.

Wang Y, Liu B, Fu L, Cui Z.

J Neurol Sci. 2015 Aug 15;355(1-2):120-4. doi: 10.1016/j.jns.2015.05.039. Epub 2015 May 31.

PMID:
26066558
19.

Can we increase the yield of FDG-PET in the preoperative work-up for epilepsy surgery?

van't Klooster MA, Huiskamp G, Zijlmans M, Debets RM, Comans EF, Bouvard S, Ryvlin P, Leijten FS.

Epilepsy Res. 2014 Aug;108(6):1095-105. doi: 10.1016/j.eplepsyres.2014.04.011. Epub 2014 May 13.

PMID:
24893829
20.

18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis.

Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, Römer W, Tatsch K, Weber W, Bartenstein P.

J Nucl Med. 1999 May;40(5):737-46.

Supplemental Content

Support Center